|
Insider Trading: Avanir Pharmaceuticals
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avanir Pharmaceuticals in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Avanir Pharmaceuticals since year 2005. Table 2 shows the detailed insider transactions of Avanir Pharmaceuticals since 2005.
The reporting company's ticker symbol is AVNR.
The reporting company's CIK number is 858803.
The total value of stock buying since 2005 is $4,564,235.
The total value of stock sales is $12,378,740.
The total value of stock exercises is $194,297.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Avanir Pharmaceuticals (AVNR) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 -
Figure 2. Average prices of insider buys, sales, and option exercises at Avanir Pharmaceuticals (AVNR) in the past 24 months. See table 2 for insider transaction details.
10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Avanir Pharmaceuticals (AVNR).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-09 | 382,527 | 356,791 | 0 | 0 | 0 | 0 |
| 2008-08 | 484,870 | 468,485 | 0 | 0 | 0 | 0 |
| 2006-05 | 26,600 | 243,369 | 1,258,242 | 12,318,188 | 50,000 | 108,500 |
| 2006-03 | 0 | 0 | 0 | 0 | 3,250 | 25,797 |
| 2006-02 | 1,000 | 15,590 | 3,600 | 60,552 | 5,000 | 60,000 |
| 2005-10 | 566,038 | 1,500,000 | 0 | 0 | 0 | 0 |
| 2005-04 | 900,000 | 1,980,000 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Avanir Pharmaceuticals (AVNR)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-09-04 | Schreiber Alain (10% Owner) | Purchase | 52,113 | .95 | 49,507 |
| 2008-09-03 | Schreiber Alain (10% Owner) | Purchase | 6,864 | .93 | 6,383 |
| 2008-09-02 | Schreiber Alain (10% Owner) | Purchase | 323,550 | .93 | 300,901 |
| 2008-08-27 | Schreiber Alain (10% Owner) | Purchase | 89,447 | .95 | 84,974 |
| 2008-08-15 | Schreiber Alain (10% Owner) | Purchase | 114,032 | .95 | 108,330 |
| 2008-08-14 | Schreiber Alain (10% Owner) | Purchase | 6,051 | .90 | 5,445 |
| 2008-08-07 | Schreiber Alain (10% Owner) | Purchase | 182,760 | .98 | 179,104 |
| 2008-08-06 | Schreiber Alain (10% Owner) | Purchase | 800 | .90 | 720 |
| 2006-05-31 | Podlesak Dennis (Director) | Purchase | 1,000 | 9.90 | 9,905 |
| 2006-05-31 | Orbimed Capital Ii Llc (Director) | Sale | 629,121 | 9.79 | 6,159,094 |
| 2006-05-31 | Silverstein Jonathan (Director) | Sale | 629,121 | 9.79 | 6,159,094 |
| 2006-05-30 | Berg James E (Vice President, Clinical) | Option Exercise | 37,500 | 2.88 | 108,000 |
| 2006-05-26 | Kaye Randall (VP of Medical Affairs) | Purchase | 2,500 | 9.96 | 24,893 |
| 2006-05-26 | Hanson Gregory P (Vice President, CAO) | Purchase | 1,100 | 9.67 | 10,639 |
| 2006-05-25 | Katkin Keith (Sr. V.P. of Sales & Marketing) | Purchase | 2,500 | 8.99 | 22,475 |
| 2006-05-25 | Puntoriero Michael J (Senior VP, Finance, CFO) | Purchase | 7,500 | 9.02 | 67,687 |
| 2006-05-25 | Brandt Eric (President, CEO & Director) | Purchase | 11,000 | 8.98 | 98,780 |
| 2006-05-25 | Emanuele Robert Martin (V P, Business Development) | Purchase | 1,000 | 8.99 | 8,990 |
| 2006-05-08 | Kaye Randall (Chief Medical Officer) | Option Exercise | 12,500 | .04 | 500 |
| 2006-03-01 | Berg James E (VP, Clinical & Reg. Affairs) | Option Exercise | 3,250 | 7.94 | 25,797 |
| 2006-02-17 | Sircar Jagadish C (VP of Drug Discovery) | Sale | 3,600 | 16.82 | 60,552 |
| 2006-02-17 | Sircar Jagadish C (VP of Drug Discovery) | Option Exercise | 5,000 | 12.00 | 60,000 |
| 2006-02-14 | Mazzo David J (Director) | Purchase | 1,000 | 15.59 | 15,590 |
| 2005-10-20 | Silverstein Jonathan (Director) | Purchase | 566,038 | 2.65 | 1,500,000 |
| 2005-04-08 | Silverstein Jonathan (Director) | Purchase | 900,000 | 2.20 | 1,980,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Avanir Pharmaceuticals (symbol AVNR,
CIK number 858803) see
the Securities and Exchange Commission (SEC) website.
|
|
